Hormone Therapy News

Undergoing postmenopausal hormone therapy for 10 years or more may increase the risk for Alzheimer’s disease, according to findings published in BMJ.

Midlife women with documented menopause symptoms are nearly twice as likely to be diagnosed with either chronic pain or chronic pain multimorbidity, independent of mental health status and other risk factors, according to findings published in Menopause.

A group of Mount Sinai researchers are piloting a new device designed to monitor two key fertility markers in women, offering a way to measure personalized reproductive health data at home, according to a press release from OOVA, a spinout company from Mount Sinai Hospital.

Transgender women experience only small changes in vitamin D-binding protein after 3 months of estradiol therapy, whereas testosterone therapy was not associated with vitamin D changes in transgender men, according to findings published in The Journal of Clinical Endocrinology & Metabolism.

Transgender women who received hormone therapy had an increased incidence of venous thromboembolic events and stroke compared with men and women not receiving hormone therapy, according to a study published in Circulation.

Among adults with growth hormone deficiency, the presence of a specific GH receptor allele influenced the level of response to GH therapy over 5 years, according to findings published in the Journal of Neuroendocrinology.

Prepubertal boys with idiopathic short stature who received growth hormone therapy for 4 years experienced an improvement in self-esteem and social functioning when compared with baseline psychosocial health scores, as well as better height perception and a diminished negative attitude toward short stature, according to an analysis of several self-report measures.

An oral dose of 100 mg progesterone in a bioidentical hormone therapy combination that includes estradiol is sufficient to counteract potential estrogenic stimulation of the endometrium while improving moderate to severe vasomotor symptoms associated with menopause, according to an analysis of hormone levels in two studies.

Children with short stature who received 1 year of growth hormone treatment experienced improvements in emotional and social quality-of-life measures when compared with baseline assessments, according to an analysis of two pediatric quality-of-life scales.

In animal models, an experimental, microneedle skin patch provided a therapeutic level of contraceptive hormone for more than 1 month with a single application to the skin, according to study findings published in Nature Biomedical Engineering.